Safety and feasibility of trans‐venous cardiac device extraction using conscious sedation alone—Implications for the post‐COVID‐19 era

Safety and feasibility of trans‐venous cardiac device extraction using conscious sedation alone—Implications for the post‐COVID‐19 era

Abstract Background Transvenous lead extraction (TLE) for implantable cardiac‐devices is traditionally performed under general anesthesia (GA). This can lead to greater risk of exposure to COVID‐19, longer recovery‐times and increased procedural‐costs. We report the feasibility/safety of TLE using c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas Lachlan, Hejie He, Hesham Aggour, Preet Sahota, Samuel Harvey, Kiran Patel, Will Foster, Shamil Yusuf, Sandeep Panikker, Tarv Dhanjal, Uday Dandekar, Thomas Barker, Jitendra Parmar, Michael Kuehl, Faizel Osman
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
cardiac implantable electronic devices
conscious‐sedation
Fentanyl
lead extraction
Midazolam
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/3efcd0eb9d094b9c8d93a3edb776efa0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/3efcd0eb9d094b9c8d93a3edb776efa0

Ejemplares similares